C&R Research Inc. (KOSDAQ:359090)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,024.00
-14.00 (-1.35%)
At close: Aug 1, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Clinical Trials for Licensing
37.00B
Log In
Log In
Clinical Trials for Licensing Growth
13.10%
Log In
Log In
Non-licensed Clinical Trials
12.12B
Log In
Log In
Non-licensed Clinical Trials Growth
19.81%
Log In
Log In
Other Service
5.97B
Log In
Log In
Other Service Growth
8.15%
Log In
Log In
Rental
12.00M
Log In
Log In
Rental Growth
-91.84%
Log In
Log In
Services
-
Log In
Log In
Delivery
-
Log In
Log In
Goods
-
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
South Korea
54.84B
Log In
Log In
South Korea Growth
15.63%
Log In
Log In
Overseas
264.83M
Log In
Log In
Overseas Growth
-75.38%
Log In
Log In